- Home
- CGTX vs JHI Comparison
CGTX vs JHI Comparison
Compare CGTX & JHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGTX
- JHI
- Stock Information
- Founded
- CGTX 2007
- JHI 1971
- Country
- CGTX United States
- JHI United States
- Employees
- CGTX N/A
- JHI N/A
- Industry
- CGTX Biotechnology: Pharmaceutical Preparations
- JHI Trusts Except Educational Religious and Charitable
- Sector
- CGTX Health Care
- JHI Finance
- Exchange
- CGTX Nasdaq
- JHI Nasdaq
- Market Cap
- CGTX 126.2M
- JHI 125.7M
- IPO Year
- CGTX 2021
- JHI N/A
- Fundamental
- Price
- CGTX $1.70
- JHI $14.05
- Analyst Decision
- CGTX Strong Buy
- JHI
- Analyst Count
- CGTX 3
- JHI 0
- Target Price
- CGTX $2.83
- JHI N/A
- AVG Volume (30 Days)
- CGTX 3.3M
- JHI 29.5K
- Earning Date
- CGTX 11-12-2025
- JHI 01-01-0001
- Dividend Yield
- CGTX N/A
- JHI 6.80%
- EPS Growth
- CGTX N/A
- JHI N/A
- EPS
- CGTX N/A
- JHI 1.05
- Revenue
- CGTX N/A
- JHI N/A
- Revenue This Year
- CGTX N/A
- JHI N/A
- Revenue Next Year
- CGTX N/A
- JHI N/A
- P/E Ratio
- CGTX N/A
- JHI $12.47
- Revenue Growth
- CGTX N/A
- JHI N/A
- 52 Week Low
- CGTX $0.22
- JHI $11.63
- 52 Week High
- CGTX $3.83
- JHI $13.40
- Technical
- Relative Strength Index (RSI)
- CGTX 52.47
- JHI 50.56
- Support Level
- CGTX $1.29
- JHI $13.91
- Resistance Level
- CGTX $1.61
- JHI $14.13
- Average True Range (ATR)
- CGTX 0.14
- JHI 0.14
- MACD
- CGTX -0.01
- JHI -0.01
- Stochastic Oscillator
- CGTX 93.62
- JHI 56.18
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
About JHI John Hancock Investors Trust
John Hancock Investors Trust is a United States-based diversified, closed-end management investment company. It seeks to generate income for distribution to its shareholders. The secondary objective of the company is capital appreciation. The portfolio composition of the fund comprises corporate bonds, U.S. government agencies, preferred securities, asset-backed securities, common stocks, short-term investments, and others.